Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Sanofi ADR (SNY) stocks

Learn how to easily invest in Sanofi ADR stocks.

Sanofi ADR is a drug manufacturers-general business based in the US. Sanofi ADR stocks (SNY.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $52.59 – a decrease of 4.43% over the previous week. Sanofi ADR employs 91,573 staff and has a trailing 12-month revenue of around $46.2 billion.

How to buy Sanofi ADR stock

  1. Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – SNY. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Promoted for Beginners


National Bank Direct Brokerage

  • Commission-free trading
  • Several account types available
  • Access to array of research tools

Promoted for Low Fees

CIBC Investor's Edge

  • Easy to use platform
  • Low fees
  • Student and young investor discounts

Best for Lowest Commissions

Finder Award

Interactive Brokers

  • Access to international stock exchanges
  • Low margin rates
  • Powerful research tools

Sanofi ADR stock price (NASDAQ:SNY)

Use our graph to track the performance of SNY stocks over time.

Sanofi ADR shares at a glance

Information last updated 2023-05-25.
Latest market close$52.59
52-week range$36.91 - $57.82
50-day moving average $53.96
200-day moving average $46.84
Wall St. target price$63.75
PE ratio 14.6212
Dividend yield $0 (3.53%)
Earnings per share (TTM) $3.59

Buy Sanofi ADR stocks from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Note: The dollar amounts in the table below are in Canadian dollars.

1 - 5 of 5
Name Product Finder Rating Available Asset Types Stock Trading Fee Account Fee Signup Offer Table description
National Bank Direct Brokerage
Finder Rating:
4.2 / 5
Stocks, Bonds, Options, Mutual Funds, GICs
$0 if conditions met, or $100
Get $0 commission on all transactions with promo code: finder
CIBC Investor's Edge
Finder Rating:
3.8 / 5
Stocks, Bonds, Options, Mutual Funds, ETFs
$0 if conditions met, or $100
An easy-to-use platform with access to a variety of tools to help you trade with confidence.
Interactive Brokers
Finder Rating:
4.3 / 5
Stocks, Bonds, Options, ETFs, Currencies, Futures
min $1.00, max 0.5%
Winner for Best Overall Broker in the Finder Stock Trading Platform Awards.
Finder Rating:
4.3 / 5
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
$4.95 - $9.95
Get $50 in free trades when you fund your account with a minimum of $1,000.
Opt for self-directed investing and save on fees or get a pre-built portfolio to take out some of the guesswork.
Qtrade Direct Investing
Finder Rating:
3.7 / 5
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Get up to $150 sign-up bonus. Use promo code BONUS150. Conditions apply. Ends June 30, 2023.
Low trading commissions and an easy-to-use platform with access to powerful tools and a wide selection of investment options.

Is it a good time to buy Sanofi ADR stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Sanofi ADR price performance over time

Historical closes compared with the close of $52.59 from 2023-05-25

1 week (2023-05-19) -4.43%
1 month (2023-04-27) -6.24%
3 months (2023-02-27) 9.91%
6 months (2022-11-25) 15.86%
1 year (2022-05-27) -4.64%
2 years (2021-05-27) -0.70%
3 years (2020-05-27) 10.74%
5 years (2018-05-25) 37.38%

Is Sanofi ADR stock undervalued or overvalued?

Valuing Sanofi ADR stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Sanofi ADR's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Sanofi ADR financials

Revenue TTM $46.2 billion
Operating margin TTM 24.43%
Gross profit TTM $31.7 billion
Return on assets TTM 5.59%
Return on equity TTM 11.77%
Profit margin 18.09%
Book value $29.85
Market capitalisation $132.7 billion

TTM: trailing 12 months

Sanofi ADR share dividends


Dividend payout ratio: 50.12% of net profits

Recently Sanofi ADR has paid out, on average, around 50.12% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.53% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Sanofi ADR shareholders could enjoy a 3.53% return on their shares, in the form of dividend payments. In Sanofi ADR's case, that would currently equate to about $0 per share.

Sanofi ADR's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.

Sanofi ADR's most recent dividend payout was on 23 June 2023. The latest dividend was paid out to all shareholders who bought their shares by 25 May 2023 (the "ex-dividend date").

Have Sanofi ADR's shares ever split?

Sanofi ADR's shares were split on a 5:1 basis on 30 September 2013. So if you had owned 1 share the day before before the split, the next day you'd have owned 5 shares. This wouldn't directly have changed the overall worth of your Sanofi ADR shares – just the quantity. However, indirectly, the new 80% lower share price could have impacted the market appetite for Sanofi ADR shares which in turn could have impacted Sanofi ADR's share price.

Sanofi ADR share price volatility

Over the last 12 months, Sanofi ADR's shares have ranged in value from as little as $36.91 up to $57.82. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Sanofi ADR's is 0.4035. This would suggest that Sanofi ADR's shares are less volatile than average (for this exchange).

Sanofi ADR overview

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as dupixent, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers body lotions, anti-itch products, moisturizing and soothing lotions, body and foot creams, and eczema powders. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for Parkinson's disease; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site